Media

Reset filters

What has happened since IMI Pain Care was launched?

Petra Bloms-Funke

Last year the European international research project IMI-PainCare started aiming at improving the care of patients suffering from acute and chronic pain.

The consortium of 40 partners from academia, small and medium-sized enterprises (SMEs), pain societies, patient organisations and companies from the pharmaceutical industry has been working together in an unprecedented close collaboration and it is a pleasure to inform you about the achievements.

Work in progress: The team managed to finalize study protocols for a couple of clinical trials in due time.

Patient engagement: Of particular note is the valuable input from the advocates of the three partner patient organizations (Pelvic pain support network, Endometriosis.org, International Painful  bladder foundation), who carefully reviewed and advised on the study protocols.

Interactions with agencies: European and US agencies (FDA, EMA, NIH), as well as experts of Health Technology Assessment are interested in IMI-PainCare and agreed to an early dialogue about the best strategy for qualification and/or integration of project outputs into regulatory practices.

Representation at pain congresses: IMI-PainCare was represented with a project booth and well-recognized at the World Pain Congress 2018 in Boston (USA). At the EFIC congress in Valencia (Spain), the IMI-PainCare team will provide more information during its workshop on 4th September, 8.30-10.00, and with a booth throughout the congress.

We are really excited about this project and hope that it will accelerate the development of innovative medicines for pain patients!

For more information please visit WWW.IMI-PAINCARE.EU.

Acknowledgement

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (IMI2 JU) under grant agreement No. 777500.

This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).

 

You can find additional information about IMI Pain Care on the following links:

- Public-private partnership tackles major challenges in pain care

- Innovative Medicine Initiative (IMI) 2 Pain Group

More on pain research:

- SIP Thematic Network - Research on pain

  • Register for the SIP Newsletter

    Stay informed about the most important events and news about the Societal Impact of Pain platform.

    subscribe now

  1. Societal Impact of Pain (SIP)
  2. Resources
  3. Resources Details